The Pioneer in JCA Management
The Joint Clinical Assessment has changed how medicines reach patients across Europe. Clever-Access was among the very first consultancies to support a product through the JCA process end to end — and we've built that experience into EUREKA, our roadmap for Health Technology Developers navigating JCA and EU HTA requirements from early development to launch.
Why Clever-Access and EUREKA
First-mover experience, deep training expertise and an active role in shaping the EU HTA ecosystem.
予測。連携。創出。成功。EUREKA!
EUREKA — the EUropean Roadmap for Empowered market Access — is our structured, strategic evidence-based roadmap guiding HTDs through the JCA process, from early development to launch.
01 Strategic Decision Making
From early development to launch, at every key milestone.
02 Evidence Optimisation
Focuses investment on the game changer data for JCA.
03 Full Alignment
Meets EU and national requirements alongside internal goals.
Key elements of EUREKA
Five integrated workstreams that anticipate JCA scoping and keep strategy on track.
PICO戦略:
HTDの戦略的フォーカスを維持しながら、JCA視点を予測し対応するための体系的な3段階アプローチ:
PICO予測:PICO調査の結果を反映した加盟国の期待値を予測する。
PICOの統合:リストを管理しやすく、JCAに関連する範囲に絞り込む。
PICO優先順位付け:EUおよび各国への申請における戦略的重点分野を定める。
プリカーサーSLR
随時更新されるエビデンス・データベースは、PICOスコーピングの段階での変化に対応し、HTDが常に一歩先んじることを可能にします。
エビデンス創出計画
臨床およびリアルワールドのデータ戦略をPICOの優先事項と整合させ、既存データ、新たなエビデンス創出の機会、およびJCAの期待を活用する。
間接比較(ITC)
比較対象とのギャップを解消し、臨床的価値に関する説明を強化するために統合された、堅牢で方法論的に健全なITC。
JCA向け申請資料作成
JCA申請を成功させ、合理化するために調整された、戦略とエビデンスのパッケージ全体をまとめた、一貫性のある説得力のある書類。
Key elements of EUREKA
Five integrated workstreams that anticipate JCA scoping and keep strategy on track.
PICO戦略:
Three-step approach — prediction, consolidation, prioritisation — to anticipate JCA scoping.
プリカーサーSLR
A living evidence database that adapts as the PICO scoping phase evolves.
エビデンス創出計画
Aligns clinical and RWE strategies with PICO priorities and JCA expectations.
間接比較(ITC)
Robust indirect treatment comparisons that close comparator gaps matching requirements.
JCA向け申請資料作成
A cohesive compliant dossier bringing the full strategy and evidence together.
Full-Service JCA & EU-HTA Support
Beyond EUREKA, our team supports every stage of the JCA and EU HTA lifecycle.
Training & Thought Leadership
Clever-Access experts are the key faculty behind two flagship EU HTA programmes.
EU HTA Masterclass
Enrollment open · Start October 5
An in-depth programme preparing professionals to lead JCA and EU HTA strategy, led by Clever-Access’s own experts, including Prof. Mondher Toumi.
IMAUD Online Market Access Course
Enrollment open · Start November 2
The IMAUD programme continues to train the next generation of market access professionals, with Clever-Access expertise at its core.
Ready to navigate JCA with confidence?
Whatever stage your product is at, our team can help you anticipate JCA requirements, build the right evidence and secure timely market access.